Aveanna Healthcare Holdings, Inc. (AVAH) · Aug 13, 2026 · Earnings

A clean revenue beat hides a 320-basis-point margin squeeze

Beat — Revenue $670.5M vs ~$638.6M consensus; FY EBITDA guide raised above $365M

Q2 revenue beat published expectations and full-year EBITDA guidance jumped, but slower profit growth and lower margins temper the headline.

The quarter cleared expectations on revenue. Q2 revenue reached $670.5 million, up 13.7% year over year, versus published expectations of roughly $638.6 million—about a 5% beat. Growth was broad: Home Health & Hospice rose 14.8%, Private Duty Services 14.0%, and Medical Solutions 9.4% (Consolidated Results; Segment Results).

MetricQ2 2025Q2 2026Change / comparison
Revenue$589.6M$670.5M+13.7% (Consolidated Results)
Gross margin dollars$210.8M$218.5M+3.7% (Consolidated Results)
Gross margin35.8%32.6%-320 bps (Consolidated Results)
Adjusted EBITDA$88.3M$95.4M+8.0% (Consolidated Results)
Free cash flow—$75.4M+$38.5M versus 2025 (Cash Flow)

The profit conversion was less impressive than the top line. Adjusted EBITDA grew 8.0%, well below revenue growth, while gross margin fell 320 basis points to 32.6%. That is close to management’s 32.2% full-year gross-margin assumption, but it shows that the revenue acceleration is not yet translating proportionally into earnings (Consolidated Results; 2026 Guidance; Segment Financial Highlights).

Management materially raised the full-year earnings framework. The presentation now calls for revenue above $2.68 billion and adjusted EBITDA above $365 million, compared with the previously communicated $2.63–$2.65 billion revenue range and $338–$342 million EBITDA range. The acquisition-related direction was already known after the Family First transaction, so the surprise is primarily the size of the updated EBITDA outlook rather than the existence of a raise (2026 Guidance).

Net read: a beat, but not a clean margin beat. The revenue upside and higher EBITDA outlook outweigh the margin compression, especially alongside $75.4 million of free cash flow. Still, the company carries $1.48 billion of variable-rate debt against $432.7 million of stated liquidity, so execution and cash conversion remain important qualifiers to the raised outlook (Capital Structure; Cash Flow).

Original filing on SEC EDGAR

More Aveanna Healthcare Holdings, Inc. news

A clean revenue beat hides a 320-basis-point margin squeeze | AVAH Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.